Neurofibromatosis type 2 is a disorder characterized by the growth of noncancerous tumors in the nervous system.
genetic conditions
References
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR.Neurofibromatosis type 2. Lancet. 2009 Jun 6;373(9679):1974-86. doi:10.1016/S0140-6736(09)60259-2.
Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. Birthincidence and prevalence of tumor-prone syndromes: estimates from a UK familygenetic register service. Am J Med Genet A. 2010 Feb;152A(2):327-32. doi:10.1002/ajmg.a.33139.
Evans DG. Neurofibromatosis 2. 1998 Oct 14 [updated 2018 Mar 15]. In: Adam MP,Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors.GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle;1993-2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK1201/
Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review.Orphanet J Rare Dis. 2009 Jun 19;4:16. doi: 10.1186/1750-1172-4-16. Review.
Hoa M, Slattery WH 3rd. Neurofibromatosis 2. Otolaryngol Clin North Am. 2012Apr;45(2):315-32, viii. doi: 10.1016/j.otc.2011.12.005. Review.
Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O,Platania N, Gabriele AL, Albanese V, Pavone L. Earliest clinical manifestationsand natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24patients. Neuropediatrics. 2005 Feb;36(1):21-34.
Contributor
MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register
: Rita Xu
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?